{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:39:08Z","timestamp":1789609148735,"version":"build-2803163510"},"reference-count":180,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.lungcan.2017.07.026","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T06:30:42Z","timestamp":1500877842000},"page":"164-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions"],"prefix":"10.1016","volume":"111","author":[{"given":"Claudine","family":"Sculier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgiana","family":"Bentea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucien","family":"Ruelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Grigoriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Coureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gorham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridon","family":"Sideris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Holbrechts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Lafitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Pascale","family":"Meert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Durieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Berghmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Sculier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.lungcan.2017.07.026_bib0005","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.lungcan.2017.07.026_bib0010","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/ana.410390516","article-title":"Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis","volume":"39","author":"Dropcho","year":"1996","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.lungcan.2017.07.026_bib0015","first-page":"881","article-title":"The expression of the Hu (paraneoplastic encephalomyelitis\/sensory neuronopathy) antigen in human normal and tumor tissues","volume":"141","author":"Dalmau","year":"1992","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/1097-0142(19950101)75:1<99::AID-CNCR2820750117>3.0.CO;2-I","article-title":"Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer","volume":"75","author":"Dalmau","year":"1995","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0025","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ana.410380117","article-title":"Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites","volume":"38","author":"Manley","year":"1995","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0304-3940(90)90314-Y","article-title":"Analysis of a neuronal antigen (Hu) expression in the developing rat brain detected by autoantibodies from patients with paraneoplastic encephalomyelitis","volume":"112","author":"Graus","year":"1990","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.lungcan.2017.07.026_bib0035","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1212\/WNL.41.10.1583","article-title":"Localization of antibody in the central nervous system of a patient with paraneoplastic encephalomyeloneuritis","volume":"41","author":"Brashear","year":"1991","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.lungcan.2017.07.026_bib0040","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1212\/WNL.45.10.1873","article-title":"Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice","volume":"45","author":"Sillevis Smitt","year":"1995","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.lungcan.2017.07.026_bib0045","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/j.1468-1331.2007.01986.x","article-title":"Imbalances in circulating lymphocyte subsets in Hu antibody associated paraneoplastic neurological syndromes","volume":"14","author":"de Beukelaar","year":"2007","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/jnnp.66.1.97","article-title":"Pattern of epitopic reactivity of the anti-Hu antibody on HuD with and without paraneoplastic syndrome","volume":"66","author":"Sodeyama","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1-2","key":"10.1016\/j.lungcan.2017.07.026_bib0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0165-5728(98)00184-2","article-title":"Antibody recognition and RNA binding of a neuronal nuclear autoantigen associated with paraneoplastic neurological syndromes and small cell lung carcinoma","volume":"93","author":"Kumagai","year":"1999","journal-title":"J. Neuroimmunol."},{"issue":"1-2","key":"10.1016\/j.lungcan.2017.07.026_bib0060","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneuroim.2008.03.002","article-title":"T cells in paraneoplastic neurological syndromes","volume":"196","author":"Tani","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1165\/ajrcmb.21.1.3625","article-title":"DNA vaccination against HuD antigen elicits antitumor activity in a small-cell lung cancer murine model","volume":"21","author":"Ohwada","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2009.03.022","article-title":"Molecular analysis of the HuD gene in neuroendocrine lung cancers","volume":"67","author":"D'Alessandro","year":"2010","journal-title":"Lung Cancer"},{"issue":"18","key":"10.1016\/j.lungcan.2017.07.026_bib0075","first-page":"4988","article-title":"Molecular analysis of the HuD gene encoding a paraneoplastic encephalomyelitis antigen in human lung cancer cell lines","volume":"54","author":"Sekido","year":"1994","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.lungcan.2017.07.026_bib0080","first-page":"412","article-title":"Paraneoplastic anti- Purkinje and type I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells","volume":"65","author":"Altermatt","year":"1991","journal-title":"Lab. Invest."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0092-8674(91)90184-Z","article-title":"a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal","volume":"67","author":"Szabo","year":"1991","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0090","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/1531-8249(199902)45:2<162::AID-ANA5>3.0.CO;2-R","article-title":"Cell- mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies","volume":"45","author":"Benyahia","year":"1999","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.lungcan.2017.07.026_bib0095","first-page":"2042","article-title":"Patients with lung cancer and paraneoplastic Hu syndrome harbor HuD-specific type 2 CD8+ T cells","volume":"119","author":"Roberts","year":"2009","journal-title":"J. Clin. Invest"},{"issue":"10","key":"10.1016\/j.lungcan.2017.07.026_bib0100","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1212\/WNL.44.10.1986-a","article-title":"Autoantibody (anti-Hu) seronegativity","volume":"44","author":"Dalmau","year":"1994","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.lungcan.2017.07.026_bib0105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3346\/jkms.1997.12.4.305","article-title":"Expression of HuD (a paraneoplastic encephalomyelitis antigen) mRNA in lung cancer","volume":"12","author":"Cho","year":"1997","journal-title":"J. Korean Med. Sci."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0165-5728(97)00199-9","article-title":"Selection of recombinant anti-HuD Fab fragments from a phage display antibody library of a lung cancer patient with paraneoplastic encephalomyelitis","volume":"82","author":"Graus","year":"1998","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF01306451","article-title":"Sera from some patients with antibody-associated paraneoplastic encephalomyelitis\/sensory neuronopathy recognize the Ro-52\u2009K antigen","volume":"19","author":"Manley","year":"1994","journal-title":"J. Neurooncol."},{"issue":"3","key":"10.1016\/j.lungcan.2017.07.026_bib0120","first-page":"3","article-title":"Autoantibodies in neurological paraneoplastic diseases","volume":"145","author":"Lovblad","year":"1994","journal-title":"Schweiz. Arch. Neurol. Psychiatr."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00415-004-0303-9","article-title":"Paraneoplastic antibodies against HuD detected by a sensitive radiobinding assay","volume":"251","author":"Storstein","year":"2004","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.lungcan.2017.07.026_bib0130","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2214\/ajr.170.6.9609164","article-title":"Association of small cell lung cancer and the anti-Hu paraneoplastic syndrome: radiographic and CT findings","volume":"170","author":"Chartrand-Lefebvre","year":"1998","journal-title":"AJR Am. J. Roentgenol."},{"issue":"Pt 6","key":"10.1016\/j.lungcan.2017.07.026_bib0135","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients","volume":"124","author":"Graus","year":"2001","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.lungcan.2017.07.026_bib0140","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.rmr.2013.05.006","article-title":"Anti-Hu antibodies: a remarkable immulogical phenotype for several paraneoplastic syndromes","volume":"30","author":"Pujol","year":"2013","journal-title":"Rev. Mal. Respir."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0145","first-page":"108","article-title":"The anti-Hu syndrome: a clinical and immunological study of 7 cases","volume":"96","author":"Pieret","year":"1996","journal-title":"Acta Neurol. Belg."},{"issue":"Pt 6","key":"10.1016\/j.lungcan.2017.07.026_bib0150","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/brain\/120.6.923","article-title":"Limbic encephalitis and small cell lung cancer. Clinical and immunological features","volume":"120","author":"Alamowitch","year":"1997","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.lungcan.2017.07.026_bib0155","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00415-002-0706-4","article-title":"Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis\/sensory neuronopathy","volume":"249","author":"Sillevis Smitt","year":"2002","journal-title":"J. Neurol."},{"issue":"Pt 6","key":"10.1016\/j.lungcan.2017.07.026_bib0160","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/brain\/awg133","article-title":"Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients","volume":"126","author":"Shams'ili","year":"2003","journal-title":"Brain"},{"issue":"1-2","key":"10.1016\/j.lungcan.2017.07.026_bib0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jns.2015.03.027","article-title":"Non-classical paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to classical syndromes \u2212 more frequent than expected","volume":"352","author":"Berger","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00005792-199203000-00001","article-title":"Anti-Hu\u2013associated paraneoplastic encephalomyelitis\/sensory neuronopathy. A clinical study of 71 patients","volume":"71","author":"Dalmau","year":"1992","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.lungcan.2017.07.026_bib0175","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1136\/jnnp.2003.033225","article-title":"Antinuclear antibodies define a subgroup of paraneoplastic neuropathies: clinical and immunological data","volume":"76","author":"Tschernatsch","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Pt 8","key":"10.1016\/j.lungcan.2017.07.026_bib0180","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/brain\/120.8.1279","article-title":"Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome","volume":"120","author":"Mason","year":"1997","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.lungcan.2017.07.026_bib0185","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1200\/JCO.1997.15.8.2866","article-title":"Anti- Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival","volume":"15","author":"Graus","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0190","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0165-5728(97)00124-0","article-title":"Paraneoplastic anti-Hu serum: studies on human tumor cell lines","volume":"79","author":"Verschuuren","year":"1997","journal-title":"J. Neuroimmunol."},{"issue":"8836","key":"10.1016\/j.lungcan.2017.07.026_bib0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0140-6736(93)92485-C","article-title":"Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies","volume":"341","author":"Darnell","year":"1993","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.lungcan.2017.07.026_bib0200","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/jnnp.62.3.276","article-title":"Spontaneous neurological improvement in anti-Hu associated encephalomyelitis","volume":"62","author":"Byrne","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.lungcan.2017.07.026_bib0205","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1017\/S0317167100002729","article-title":"Paraneoplastic sensory neuronopathy and spontaneous regression of small cell lung cancer","volume":"30","author":"Gill","year":"2003","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.lungcan.2017.07.026_bib0210","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.01.2009.1486","article-title":"Paraneoplastic sensorimotor neuropathy associated with regression of small cell lung carcinoma","author":"Mawhinney","year":"2010","journal-title":"BMJ Case Rep."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/JTO.0b013e31802f1c9d","article-title":"Spontaneous complete remission of a non-small cell lung cancer associated with anti-Hu antibody syndrome","volume":"2","author":"Pujol","year":"2007","journal-title":"J. Thorac. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0220","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.lungcan.2007.05.005","article-title":"A case of spontaneous regression of small cell lung cancer with progression of paraneoplastic sensory neuropathy","volume":"58","author":"Hirano","year":"2007","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2017.07.026_bib0225","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.410270515","article-title":"Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer?a quantitative western blot analysis","volume":"27","author":"Dalmau","year":"1990","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.lungcan.2017.07.026_bib0230","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/WNL.0000000000001721","article-title":"Paraneoplastic neurologic disorders in small cell lung carcinoma: a prospective study","volume":"85","author":"Gozzard","year":"2015","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.lungcan.2017.07.026_bib0235","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00262-009-0690-y","article-title":"Onconeural antibodies in sera from patients with various types of tumours","volume":"58","author":"Monstad","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.lungcan.2017.07.026_bib0240","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.2004.01.028","article-title":"Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer","volume":"22","author":"Monstad","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2017.07.026_bib0245","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/jnnp.2007.138016","article-title":"Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2\/CRMP5 antibodies","volume":"80","author":"Honnorat","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.lungcan.2017.07.026_bib0250","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jnnp.68.4.479","article-title":"Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone","volume":"68","author":"Keime-Guibert","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.lungcan.2017.07.026_bib0255","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.60.4.388","article-title":"Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies","volume":"60","author":"Uchuya","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.lungcan.2017.07.026_bib0260","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ana.410140603","article-title":"Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma","volume":"14","author":"Greenlee","year":"1983","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0265","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2990.2007.00909.x","article-title":"Neocortical neurones may be targeted by immune attack in anti-Yo paraneoplastic syndrome","volume":"34","author":"Aboul-Enein","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"725936","key":"10.1016\/j.lungcan.2017.07.026_bib0270","article-title":"Anti-yo associated paraneoplastic cerebellar degeneration in a man with large cell cancer of the lung","volume":"2013","author":"Hasadsri","year":"2013","journal-title":"case report"},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0275","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.10587","article-title":"Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5- IgG","volume":"54","author":"Cross","year":"2003","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0280","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","article-title":"CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity","volume":"49","author":"Yu","year":"2001","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.lungcan.2017.07.026_bib0285","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1046\/j.1460-9568.1999.00864.x","article-title":"Ulip\/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromes","volume":"11","author":"Honnorat","year":"1999","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.lungcan.2017.07.026_bib0290","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.20269","article-title":"Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome","volume":"56","author":"Pittock","year":"2004","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.lungcan.2017.07.026_bib0295","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.10178","article-title":"Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma","volume":"51","author":"Vernino","year":"2002","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0300","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00262-007-0369-1","article-title":"CRMP5 antibodies in patients with small-cell lung cancer or thymoma","volume":"57","author":"Monstad","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"issue":"3","key":"10.1016\/j.lungcan.2017.07.026_bib0305","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/jnnp.61.3.270","article-title":"Antibodies to a subpopulation of glial cells and a 66\u2009kDa developmental protein in patients with paraneoplastic neurological syndromes","volume":"61","author":"Honnorat","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0310","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1385\/CRIAI:19:1:51","article-title":"Anti-CV2 autoantibodies and paraneoplastic neurological syndromes","volume":"19","author":"Rogemond","year":"2000","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.lungcan.2017.07.026_bib0315","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archneur.55.3.405","article-title":"Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies: clinical response to excision of the primary tumor","volume":"55","author":"de la Sayette","year":"1998","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.lungcan.2017.07.026_bib0320","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.neurol.2011.07.016","article-title":"Neurologic paraneoplastic syndrome with anti-CV2\/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment","volume":"168","author":"Rosencher","year":"2012","journal-title":"Rev. Neurol. (Paris)"},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0325","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neurol.2009.04.009","article-title":"Paraneoplastic chorea and behavioral disorders in a patient with anti-CV2\/CRMP5 antibodies and two different tumors","volume":"166","author":"Ritzenthaler","year":"2010","journal-title":"Rev. Neurol. (Paris)"},{"issue":"4","key":"10.1016\/j.lungcan.2017.07.026_bib0330","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/ana.21324","article-title":"Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G","volume":"63","author":"Keegan","year":"2008","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.lungcan.2017.07.026_bib0335","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.10518","article-title":"Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments","volume":"53","author":"Pittock","year":"2003","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0340","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11060-008-9650-1","article-title":"Paraneoplastic opsoclonus-myoclonus ataxia associated with non-small-cell lung carcinoma","volume":"90","author":"Musunuru","year":"2008","journal-title":"J. Neurooncol."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0345","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1081\/CNV-120030214","article-title":"ANNA-2: an antibody associated with paraneoplastic opsoclonus in a patient with large-cell carcinoma of the lung with neuroendocrine features\u2013correlation of clinical improvement with tumor response","volume":"22","author":"Erlich","year":"2004","journal-title":"Cancer Invest."},{"issue":"11","key":"10.1016\/j.lungcan.2017.07.026_bib0350","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1007\/s00415-005-0841-9","article-title":"Anti-Ri antibodies and limbic encephalitis in a patient with carcinoid tumour of the lung","volume":"252","author":"Harloff","year":"2005","journal-title":"J. Neurol."},{"issue":"8","key":"10.1016\/j.lungcan.2017.07.026_bib0355","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/01.WNL.0000123694.64121.D5","article-title":"Paraneoplastic stiff person syndrome with metastatic adenocarcinoma and anti-Ri antibodies","volume":"62","author":"McCabe","year":"2004","journal-title":"Neurology"},{"issue":"Pt 8","key":"10.1016\/j.lungcan.2017.07.026_bib0360","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.lungcan.2017.07.026_bib0365","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.2007.118588","article-title":"Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases","volume":"79","author":"Hoffmann","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0370","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1212\/01.wnl.0000223647.83708.20","article-title":"Early pathologic findings and long-term improvement in anti-Ma2-associated encephalitis","volume":"67","author":"Blumenthal","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0375","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1215\/15228517-2006-013","article-title":"Hypersomnia as presenting symptom of anti-Ma2-associated encephalitis: case study","volume":"9","author":"Rojas-Marcos","year":"2007","journal-title":"Neuro-Oncol."},{"issue":"6-7","key":"10.1016\/j.lungcan.2017.07.026_bib0380","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neurol.2008.03.005","article-title":"Ma2 antibody and multiple mononeuropathies","volume":"164","author":"Ayrignac","year":"2008","journal-title":"Rev. Neurol. (Paris)"},{"issue":"Pt 7","key":"10.1016\/j.lungcan.2017.07.026_bib0385","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","article-title":"Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients","volume":"123","author":"Gultekin","year":"2000","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0390","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/archneur.56.2.172","article-title":"Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors","volume":"56","author":"Antoine","year":"1999","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0395","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/jnnp.66.2.214","article-title":"Anti- amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma","volume":"66","author":"Saiz","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0400","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ana.20529","article-title":"Amphiphysin autoimmunity: paraneoplastic accompaniments","volume":"58","author":"Pittock","year":"2005","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.lungcan.2017.07.026_bib0405","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/mds.20910","article-title":"Antiamphiphysin-positive stiff-person syndrome associated with small cell lung cancer","volume":"21","author":"Nguyen-Huu","year":"2006","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.lungcan.2017.07.026_bib0410","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/MAO.0b013e318064e8fe","article-title":"Paraneoplastic effects on neurophthalmologic function","volume":"28","author":"Ray","year":"2007","journal-title":"Otol. Neurotol."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0415","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000092307","article-title":"Paraneoplastic rhombencephalitis and brachial plexopathy in two cases of amphiphysin auto- immunity","volume":"55","author":"Coppens","year":"2006","journal-title":"Eur. Neurol."},{"issue":"9468","key":"10.1016\/j.lungcan.2017.07.026_bib0420","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0140-6736(05)66376-3","article-title":"Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin","volume":"365","author":"Sommer","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0425","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.0b013e318224afde","article-title":"Encephalitis and antibodies to synaptic and neuronal cell surface proteins","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"issue":"Pt 3","key":"10.1016\/j.lungcan.2017.07.026_bib0430","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody- associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.lungcan.2017.07.026_bib0435","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/jnnp.2006.100644","article-title":"Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes","volume":"78","author":"Bataller","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0440","first-page":"139","article-title":"Steroid-responsive recurrent limbic encephalitis associated with small cell lung cancer and neuropil antibodies","volume":"111","author":"Tuzun","year":"2011","journal-title":"Acta Neurol. Belg."},{"issue":"12","key":"10.1016\/j.lungcan.2017.07.026_bib0445","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/01.wnl.0000325917.48466.55","article-title":"Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations","volume":"71","author":"Graus","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0450","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neurol.2012.05.014","article-title":"Autoimmune encephalitis, clinical, radiological and immunological data","volume":"169","author":"Aupy","year":"2013","journal-title":"Rev. Neurol. (Paris)"},{"issue":"5 Pt 2","key":"10.1016\/j.lungcan.2017.07.026_bib0455","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S0035-3787(04)71002-4","article-title":"Dosage and specificity of anti-calcium channel antibodies in Lambert-Eaton myasthenic syndrome","volume":"160","author":"Martin-Moutot","year":"2004","journal-title":"Rev. Neurol. (Paris)"},{"issue":"7","key":"10.1016\/j.lungcan.2017.07.026_bib0460","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1073\/pnas.0710771105","article-title":"Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo","volume":"105","author":"Liao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.lungcan.2017.07.026_bib0465","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.59.5.764","article-title":"P\/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer","volume":"59","author":"Graus","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0470","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12311-015-0664-x","article-title":"Consensus paper neuroimmune mechanisms of cerebellar ataxias","volume":"15","author":"Mitoma","year":"2016","journal-title":"Cerebellum (Lond., Engl.)"},{"issue":"6039","key":"10.1016\/j.lungcan.2017.07.026_bib0475","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/317737a0","article-title":"Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line","volume":"317","author":"Roberts","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2017.07.026_bib0480","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jneuroim.2008.06.031","article-title":"Calcium channels, neuromuscular synaptic transmission and neurological diseases","volume":"201-202","author":"Urbano","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0485","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/WNL.50.2.475","article-title":"Antibodies against the calcium channel beta-subunit in Lambert-Eaton myasthenic syndrome","volume":"50","author":"Verschuuren","year":"1998","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0490","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.410420204","article-title":"Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse","volume":"42","author":"Waterman","year":"1997","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0495","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ana.10497","article-title":"Do calcium channel autoantibodies cause cerebellar ataxia with Lambert-Eaton syndrome?","volume":"53","author":"Fletcher","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.lungcan.2017.07.026_bib0500","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1752-1947-4-95","article-title":"Paraneoplastic limbic encephalitis presenting as a neurological emergency: a case report","volume":"4","author":"Xia","year":"2010","journal-title":"J. Med. Case Rep."},{"issue":"4","key":"10.1016\/j.lungcan.2017.07.026_bib0505","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3171\/JNS\/2008\/109\/10\/0742","article-title":"Temporal lobectomy for refractory status epilepticus in a case of limbic encephalitis","volume":"109","author":"Weimer","year":"2008","journal-title":"J. Neurosurg."},{"issue":"6","key":"10.1016\/j.lungcan.2017.07.026_bib0510","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s10072-011-0648-7","article-title":"VGCC antibody-positive paraneoplastic cerebellar degeneration presenting with positioning vertigo","volume":"32","author":"Ogawa","year":"2011","journal-title":"Neurol. Sci."},{"issue":"3","key":"10.1016\/j.lungcan.2017.07.026_bib0515","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/jnnp.2009.172684","article-title":"Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer","volume":"82","author":"Simister","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0520","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0303-8467(03)00059-3","article-title":"Complicated paraneoplastic neurological syndromes: a report of two patients with small cell or non-small cell lung cancer","volume":"106","author":"Hiasa","year":"2003","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"8","key":"10.1016\/j.lungcan.2017.07.026_bib0525","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.lungcan.2017.07.026_bib0530","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"issue":"20","key":"10.1016\/j.lungcan.2017.07.026_bib0535","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1212\/01.wnl.0000312275.04260.a0","article-title":"Clinical spectrum of voltage-gated potassium channel autoimmunity","volume":"70","author":"Tan","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.lungcan.2017.07.026_bib0540","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"SR","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.lungcan.2017.07.026_bib0545","first-page":"227","article-title":"Autoimmune epilepsy","volume":"22","author":"Gaspard","year":"2016","journal-title":"Continuum (Minneapolis, Minn.)"},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0550","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.24200","article-title":"Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms","volume":"76","author":"Irani","year":"2014","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0555","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann. Neurol."},{"issue":"Pt 8","key":"10.1016\/j.lungcan.2017.07.026_bib0560","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/awf178","article-title":"Phenotypic variants of autoimmune peripheral nerve hyperexcitability","volume":"125","author":"Hart","year":"2002","journal-title":"Brain"},{"issue":"Pt 12","key":"10.1016\/j.lungcan.2017.07.026_bib0565","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/brain\/124.12.2417","article-title":"Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels","volume":"124","author":"Liguori","year":"2001","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.lungcan.2017.07.026_bib0570","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.lungcan.2017.07.026_bib0575","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.0b013e3181d3e404","article-title":"The expanding clinical profile of anti-AMPA receptor encephalitis","volume":"74","author":"Graus","year":"2010","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.lungcan.2017.07.026_bib0580","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","article-title":"Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients","volume":"84","author":"Hoftberger","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0585","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0590","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11060-004-2276-z","article-title":"Paraneoplastic recurrent multifocal encephalitis presenting with epilepsia partialis continua","volume":"72","author":"Mut","year":"2005","journal-title":"J. Neurooncol."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0595","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11060-004-2242-9","article-title":"Focal paraneoplastic limbic encephalitis presenting as orgasmic epilepsy","volume":"72","author":"Fadul","year":"2005","journal-title":"J. Neurooncol."},{"issue":"9","key":"10.1016\/j.lungcan.2017.07.026_bib0600","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/WNL.0b013e31820e7b8d","article-title":"GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders","volume":"76","author":"Boronat","year":"2011","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.lungcan.2017.07.026_bib0605","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","article-title":"Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients","volume":"81","author":"Hoftberger","year":"2013","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.lungcan.2017.07.026_bib0610","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1212\/WNL.0b013e3182a35271","article-title":"GABAB receptor autoantibody frequency in service serologic evaluation","volume":"81","author":"Jeffery","year":"2013","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.lungcan.2017.07.026_bib0615","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archneurol.2009.78","article-title":"Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments","volume":"66","author":"McKeon","year":"2009","journal-title":"Arch. Neurol."},{"issue":"11","key":"10.1016\/j.lungcan.2017.07.026_bib0620","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1468-1331.2007.01931.x","article-title":"Autoantibodies against M1 muscarinic acetylcholine receptor in myasthenic disorders","volume":"14","author":"Takamori","year":"2007","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.lungcan.2017.07.026_bib0625","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3988\/jcn.2012.8.4.305","article-title":"A case of lambert-eaton myasthenic syndrome with small-cell lung cancer and transient increase in anti-acetylcholine-receptor-binding antibody titer","volume":"8","author":"Lee","year":"2012","journal-title":"J. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0630","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.lungcan.2017.07.026_bib0635","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1212\/WNL.0000000000000131","article-title":"Seizures as first symptom of anti-NMDA receptor encephalitis are more common in men","volume":"82","author":"Titulaer","year":"2014","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.lungcan.2017.07.026_bib0640","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.lungcan.2017.07.026_bib0645","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clineuro.2011.10.015","article-title":"encephalitis in small-cell lung cancer: a case report","volume":"114","author":"Uruha","year":"2012","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"5","key":"10.1016\/j.lungcan.2017.07.026_bib0650","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archneur.65.5.629","article-title":"Aquaporin-4 autoantibodies in a paraneoplastic context","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.lungcan.2017.07.026_bib0655","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10072-009-0112-0","article-title":"A possible paraneoplastic neuromyelitis optica associated with lung cancer","volume":"30","author":"De Santis","year":"2009","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.lungcan.2017.07.026_bib0660","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.clineuro.2005.01.008","article-title":"Probably anti-Tr associated paraneoplastic cerebellar degeneration as initial presentation of a squamous cell carcinoma of the lung","volume":"108","author":"Bruylant","year":"2006","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"3","key":"10.1016\/j.lungcan.2017.07.026_bib0665","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ana.1127","article-title":"ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity","volume":"50","author":"Chan","year":"2001","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.lungcan.2017.07.026_bib0670","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1531-8249(200003)47:3<297::AID-ANA4>3.0.CO;2-4","article-title":"New Purkinje cell antibody (PCA-2): marker of lung cancer- related neurological autoimmunity","volume":"47","author":"Vernino","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.lungcan.2017.07.026_bib0675","article-title":"Paraneoplastic optic neuropathy associated with purkinje cell antibody-2 in a patient with small cell lung cancer","author":"Micieli","year":"2016","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.lungcan.2017.07.026_bib0680","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-215158","article-title":"Double trouble: para-neoplastic anti-PCA-2 and CRMP-5-mediated small fibre neuropathy followed by chorea associated with small cell lung cancer and evolving radiological features","volume":"2016","author":"Waheed","year":"2016","journal-title":"BMJ Case Rep."},{"issue":"1-2","key":"10.1016\/j.lungcan.2017.07.026_bib0685","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jneuroim.2005.08.011","article-title":"BR serine\/threonine kinase 2: a new autoantigen in paraneoplastic limbic encephalitis","volume":"170","author":"Sabater","year":"2005","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.lungcan.2017.07.026_bib0690","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1212\/01.WNL.0000113749.77217.01","article-title":"Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer","volume":"62","author":"Bataller","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.lungcan.2017.07.026_bib0695","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jneuroim.2008.01.018","article-title":"ZIC antibodies in paraneoplastic cerebellar degeneration and small cell lung cancer","volume":"201-202","author":"Sabater","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.lungcan.2017.07.026_bib0700","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1073\/pnas.97.8.4198","article-title":"Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer","volume":"97","author":"Gure","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.lungcan.2017.07.026_bib0705","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1212\/01.WNL.0000038352.01415.CE","article-title":"Cerebellar degeneration and autoimmunity to zinc-finger proteins of the cerebellum","volume":"59","author":"Bataller","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.lungcan.2017.07.026_bib0710","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.neurol.2011.07.018","article-title":"Anti- GAD antibodies in paraneoplastic cerebellar ataxia associated with limbic encephalitis andautonomic dysfunction","volume":"168","author":"Carra-Dalliere","year":"2012","journal-title":"Rev. Neurol. (Paris)"},{"issue":"2B","key":"10.1016\/j.lungcan.2017.07.026_bib0715","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1590\/S0004-282X2004000300033","article-title":"Progressive encephalomyelitis with rigidity: a paraneoplastic presentation of oat cell carcinoma of the lung. Case report","volume":"62","author":"Spitz","year":"2004","journal-title":"Arq. Neuropsiquiatr."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0720","first-page":"283","article-title":"Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy","volume":"38","author":"Adamus","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0725","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2005.11.007","article-title":"Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells","volume":"26","author":"Adamus","year":"2006","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.lungcan.2017.07.026_bib0730","first-page":"705","article-title":"Mechanisms of photoreceptor cell death in cancer-associated retinopathy","volume":"42","author":"Maeda","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.lungcan.2017.07.026_bib0735","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1006\/jaut.1998.0221","article-title":"Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo","volume":"11","author":"Adamus","year":"1998","journal-title":"J. Autoimmun."},{"issue":"2-3","key":"10.1016\/j.lungcan.2017.07.026_bib0740","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0169-5002(96)00552-1","article-title":"Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity","volume":"14","author":"Matsubara","year":"1996","journal-title":"Lung Cancer"},{"issue":"20","key":"10.1016\/j.lungcan.2017.07.026_bib0745","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1073\/pnas.92.20.9176","article-title":"Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy","volume":"92","author":"Polans","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0750","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.lungcan.2003.10.006","article-title":"Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors","volume":"44","author":"Bazhin","year":"2004","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2017.07.026_bib0755","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9394(02)01633-1","article-title":"Antirecoverin antibody in the aqueous humor of a patient with cancer-associated retinopathy","volume":"134","author":"Ohguro","year":"2002","journal-title":"Am. J. Ophthalmol."},{"issue":"19","key":"10.1016\/j.lungcan.2017.07.026_bib0760","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1200\/JCO.2010.33.1371","article-title":"Seventeen-year survival of small-cell lung carcinoma presenting as carcinoma-associated retinopathy","volume":"29","author":"Stanescu-Segall","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2017.07.026_bib0765","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.lungcan.2007.02.015","article-title":"Long-term survival of a patient with small cell lung cancer associated with cancer-associated retinopathy","volume":"57","author":"Kobayashi","year":"2007","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2017.07.026_bib0770","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lungcan.2014.10.015","article-title":"Spontaneous regression of small cell lung cancer combined with cancer associated retinopathy","volume":"87","author":"Kitai","year":"2015","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0775","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/1521-4141(200102)31:2<563::AID-IMMU563>3.0.CO;2-D","article-title":"Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome","volume":"31","author":"Maeda","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0780","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10875-006-9065-8","article-title":"The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy","volume":"27","author":"Magrys","year":"2007","journal-title":"J. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.lungcan.2017.07.026_bib0785","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/IAE.0000000000000119","article-title":"Autoimmune retinopathy and antiretinal antibodies: a review","volume":"34","author":"Grewal","year":"2014","journal-title":"Retina"},{"issue":"1-2","key":"10.1016\/j.lungcan.2017.07.026_bib0790","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneuroim.2005.03.020","article-title":"Anti- glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes","volume":"165","author":"Graus","year":"2005","journal-title":"J. Neuroimmunol."},{"issue":"12","key":"10.1016\/j.lungcan.2017.07.026_bib0795","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/01.wnl.0000281663.81079.24","article-title":"SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome","volume":"70","author":"Sabater","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.lungcan.2017.07.026_bib0800","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-0404.2011.01572.x","article-title":"SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes","volume":"125","author":"Stich","year":"2012","journal-title":"Acta Neurol. Scand."},{"issue":"3","key":"10.1016\/j.lungcan.2017.07.026_bib0805","doi-asserted-by":"crossref","first-page":"e60438","DOI":"10.1371\/journal.pone.0060438","article-title":"Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer","volume":"8","author":"Sabater","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2017.07.026_bib0810","series-title":"Evidence-based Medicine: How to Practice and Teach EBM","author":"Sackett","year":"2000"},{"key":"10.1016\/j.lungcan.2017.07.026_bib0815","series-title":"Paraneoplastic Syndromes: 22 Tables","year":"2017"},{"issue":"11","key":"10.1016\/j.lungcan.2017.07.026_bib0820","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jclinepi.2014.05.008","article-title":"Meta- epidemiologic analysis indicates that MEDLINE searches are sufficient for diagnostic test accuracy systematic reviews","volume":"67","author":"van Enst","year":"2014","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.lungcan.2017.07.026_bib0825","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jpsychores.2016.06.002","article-title":"Are MEDLINE searches sufficient for systematic reviews and meta-analyses of the diagnostic accuracy of depression screening tools? A review of meta-analyses","volume":"87","author":"Rice","year":"2016","journal-title":"J. Psychosom. Res."},{"issue":"10","key":"10.1016\/j.lungcan.2017.07.026_bib0830","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0895-4356(03)00110-0","article-title":"Should meta-analysts search Embase in addition to Medline?","volume":"56","author":"M","year":"2003","journal-title":"J. Clin. Epidemiol."},{"issue":"6","key":"10.1016\/j.lungcan.2017.07.026_bib0835","doi-asserted-by":"crossref","first-page":"484","DOI":"10.5271\/sjweh.3082","article-title":"Searching for high-quality articles about intervention studies in occupational health \u2212 what is really missed when using only the Medline database?","volume":"36","author":"Rollin","year":"2010","journal-title":"Scand. J. Work Environ. Health"},{"issue":"4","key":"10.1016\/j.lungcan.2017.07.026_bib0840","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/annonc\/mdv623","article-title":"Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper","volume":"27","author":"Champiat","year":"2016","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0845","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/art.39406","article-title":"Autoimmune arthropathy and uveitis as complications of programmed death 1 inhibitor treatment","volume":"68","author":"de Velasco","year":"2016","journal-title":"Arthriti Rheumatol. (Hoboken, N. J.)"},{"issue":"3","key":"10.1016\/j.lungcan.2017.07.026_bib0850","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJMc1515584","article-title":"Pembrolizumab-Induced demyelinating polyradiculoneuropathy","volume":"375","author":"MF","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.lungcan.2017.07.026_bib0855","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/cas.12961","article-title":"Myasthenic crisis and polymyositis induced by one dose of nivolumab","volume":"107","author":"Kimura","year":"2016","journal-title":"Cancer Sci."},{"issue":"8","key":"10.1016\/j.lungcan.2017.07.026_bib0860","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1001\/jamaneurol.2016.1399","article-title":"Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer","volume":"73","author":"Williams","year":"2016","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.lungcan.2017.07.026_bib0865","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00281-016-0595-8","article-title":"Cancer immunotherapy in patients with preexisting autoimmune disorders","volume":"39","author":"Donia","year":"2017","journal-title":"Semin. Immunopathol."},{"issue":"2","key":"10.1016\/j.lungcan.2017.07.026_bib0870","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/jamaoncol.2015.4368","article-title":"Ipilimumab therapy in patients with advanced melanoma and preexisting autoimmune disorders","volume":"2","author":"DB","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.lungcan.2017.07.026_bib0875","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-94-007-4549-0_40","article-title":"Neurological paraneoplastic syndromes in lung cancer patients","volume":"756","author":"Stefens-Stawna","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"issue":"10","key":"10.1016\/j.lungcan.2017.07.026_bib0880","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/jnnp.2003.025171","article-title":"A follow up study of patients with paraneoplastic neurological disease in the United Kingdom","volume":"75","author":"Candler","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"11","key":"10.1016\/j.lungcan.2017.07.026_bib0885","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4065\/78.11.1363","article-title":"Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis","volume":"78","author":"Lawn","year":"2003","journal-title":"Mayo Clin. Proc."},{"issue":"11","key":"10.1016\/j.lungcan.2017.07.026_bib0890","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1007\/s00415-011-6074-1","article-title":"Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience","volume":"258","author":"Vigliani","year":"2011","journal-title":"J. Neurol."},{"issue":"Pt 2","key":"10.1016\/j.lungcan.2017.07.026_bib0895","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/brain\/124.2.437","article-title":"Spanish Opsoclonus-Myoclonus Study, clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus","volume":"124","author":"Bataller","year":"2001","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.lungcan.2017.07.026_bib0900","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/archneurol.2012.1173","article-title":"Adult-onset opsoclonus-myoclonus syndrome","volume":"69","author":"Klaas","year":"2012","journal-title":"Arch. Neurol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500217304142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500217304142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T17:30:21Z","timestamp":1750786221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500217304142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":180,"alternative-id":["S0169500217304142"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2017.07.026","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2017.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}